About Denali Therapeutics (DNLI) ; Today's range. $ - $ ; Debt / equity. x ; 52 week range. $ - $ ; 5 year debt / equity. x ; Beta (LTM). The current price of DNLI is USD — it hasn't changed in the past 24 hours. Watch Denali Therapeutics Inc. stock price performance more closely on the. Nurix Therapeutics Inc. $ NRIX % ; Ultragenyx Pharmaceutical Inc. $ RARE % ; Intellia Therapeutics Inc. $ NTLA % ; Biogen Inc. Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for. Denali Therapeutics (DNLI) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom.
Denali Therapeutics Inc. ; Market Value, $B ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Key statistics for Denali Therapeutics Inc (DNLI | USRUSD) plus portfolio overview, latest price and performance data, expert insights and more. Denali Therapeutics Inc DNLI:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date08/26/24 · 52 Week Low. According to 10 analysts, the average rating for DNLI stock is "Strong Buy." The month stock price forecast is $, which is an increase of % from the. On average, Wall Street analysts predict that Denali Therapeutics's share price could reach $ by Aug 15, The average Denali Therapeutics stock price. Denali Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. DNLI updated stock price target summary. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Over the last year, Denali Therapeutics shares have traded in a share price range of $ to $ Denali Therapeutics currently has ,, shares. Denali Therapeutics Inc (DNLI) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. The 35 analysts offering price forecasts for Denali Therapeutics have a median target of , with a high estimate of and a low estimate of Denali Therapeutics Inc. ; Prev. Close. ; Low. ; 52wk Low. ; Market Cap. b ; Total Shares. m.
Denali Therapeutics Inc., a biopharmaceutical company, develops a portfolio of product candidates engineered to cross the blood-brain barrier for. Denali down 10% on pause in neurological drug. Denali Therapeutics Inc. shares fell 10% to $ as the company said it will pause clinical studies with. Why Denali Therapeutics' Stock Rose % on Wednesday. The biopharmaceutical stock was actually up as much as % before falling a bit at the close. Denali Therapeutics/DNLI ; After hours · $ % ; DNLI Metrics. BasicAdvanced ; Analyst Ratings. Analyst ratings (Buy, Hold, Sell) for Denali Therapeutics. Denali Therapeutics (NASDAQ:DNLI) shareholders are up % this past week, but still in the red over the last three years. Denali Therapeutics Inc. (NASDAQ. Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering the Show More. Compare. Discover real-time Denali Therapeutics Inc. Common Stock (DNLI) stock prices, quotes, historical data, news, and Insights for informed trading and. Denali Therapeutics Inc. ; Volume, M ; Market Value, $B ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. Latest Denali Therapeutics Inc (DNLI:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and.
Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-. Denali Therapeutics is dedicated to defeating neurodegenerative and lysosomal storage diseases through rigorous therapeutic discovery and development. The Time. Denali Therapeutics Inc · PM, Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. · AM, Join thousands of. Track Denali Therapeutics Inc (DNLI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and. The share price as of September 3, is / share. Previously, on September 5, , the share price was / share. This represents an increase of.
Price Target. The average one-year price target for Denali Therapeutics Inc. is $ The forecasts range from a low of $ to a high of $ A stock's. (NASDAQ: DNLI) Denali Therapeutics's week high was $, and its week low was $ It is currently % from its week high and % from its Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The. Stock prices are delayed, the delay can range from a few minutes to several hours. Company logos are from the web-slide.ru logo database and belong to. Denali Therapeutics Inc. (NASDAQ: DNLI) is a leading biotechnology company based in South San Francisco, focused on the discovery and development of. Denali Therapeutics Inc. operates as a biotechnology company. The Company discovers and develops medicines for neurodegenerative diseases. Denali Therapeutics.
Can I Read Quran In English | Mortgage And Tax Calculator California